Booking & Referral Information
Please note: Ghel will be closed from 04/05/26, and will reopen on 11/05/26.
Upcoming Planned Closure Dates
Please note: within the next 2 months…Ghel will be closed from 28/09/2026 and will reopen on 12/10/2026
Here you find everything about the booking process and what we need for it
Ghel Practice:
- DWS provider number (Ocean Reef)
- 100% telehealth
- Nationwide availability
- No Waitlist / prompt intervention
- WA-based psychiatrist
- Medicare rebates available
- Rapid booking & response times
Telehealth only
Referrals
We accept referrals for
- ADHD assessments
Item 291
Item 291 including ongoing management/titration if clinically required.
Item 296 - ADHD review
Item 293 within a year after diagnosis by us
Item 291 otherwise - Diagnostic psychiatric evaluations
Item 291 once-off
Item 296 and ongoing care - Ongoing medication management.
Item 296
Referral options for GPs/referrers
A. Mental Health Assessment + Ongoing Care
Item 296
For adjustment disorder, anxiety, depression, trauma, personality vulnerabilities, bipolar, OCD, etc.
Ongoing care by psychiatrist
(Psychiatric diagnosis, treatment planning & follow-up)Medication reviews via telehealth (item 92433 or 92434)
B. ADHD Assessment + GP-led Stimulant Prescribing
- Item 291 or 296
291 is used for a comprehensive psychiatric assessment and management plan. Where ongoing medication titration is required, the referral should clearly request assessment and management, including ongoing management/titration if clinically required.
296 provides for ongoing specialist psychiatric care and can be used where ongoing assessment and management, including medication titration, is required.
For ADHD assessments a “291 including ongoing management/titration if clinically required” can be the most cost effective way.
Comprehensive ADHD assessment and written stimulant management plan
Ongoing care by GP, where clinically appropriate and permitted under applicable state or territory requirements
Specialist review: An Item 293 may be used for a review of the management plan within the 12 months following an Item 291 service, subject to the MBS requirements.
After the 12-month period, where a further comprehensive specialist assessment and management plan is clinically required, an appropriate referral for a new Item 291/92435 may provide a more cost-effective Medicare pathway than an ongoing review item, subject to the clinical circumstances and MBS eligibility. This is particularly relevant to patients considering the cost of ongoing specialist care.
C. ADHD Assessment + Psychiatrist-led Medication Management
Item 296
Comprehensive ADHD assessment and diagnosisOngoing care by psychiatrist
(stimulant titration & psychiatric follow-up)
Short (15–30 min) or long (>30 min) follow-ups available
(This option includes (A.) respectively a Complete Mental Health Assessment and adds a check for ADHD)
Pre-Referral Investigations (Needed, if medication is recommended)
Please ensure the following have been completed (especially for ADHD medication / medication reviews):
- UDS – Urine drug screen (for medication. Instant or blood based)
- ECG (Mentioning clearance on referral is enough)
(stimulant prescribing considered, cardiac history, psychotropic medication likely to be prescribed) - BP-Blood Pressure
Recommended or if available:
- Height, weight, BMI
FBC, U&E, LFTs
TSH, B12, folate, iron studies
Fasting glucose or HbA1c, lipids
- Cardiovascular exam and auscultation
Patient has to be medically cleared / must not have known contraindications to stimulant or psychotropic medications.
If any concerns identified, please provide a summary.